Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
UC San Diego Medical Center
mi
from
San Diego, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
UC San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
California Pacific Medical Center
mi
from
San Francisco, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Joseph's Medical Center- CA
mi
from
Stockton, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Joseph's Medical Center- CA
mi
from
Stockton, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Medical Center of Aurora
mi
from
Aurora, CO
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Medical Center of Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Bridgeport Hospital
mi
from
Bridgeport, CT
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Bay Area Cardiology Associates/ Brandon Regional Hospital
mi
from
Brandon, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Bay Area Cardiology Associates/ Brandon Regional Hospital
mi
from
Brandon, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Diagnostic Cardiology Associates
mi
from
Lauderdale Lakes, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Diagnostic Cardiology Associates
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Munroe Regional Medical Center
mi
from
Ocala, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Munroe Regional Medical Center
mi
from
Ocala, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Ocala Regional Medical Center
mi
from
Ocala, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Ocala Regional Medical Center
mi
from
Ocala, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Florida Hospital
mi
from
Orlando, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sacred Heart Hospital
mi
from
Pensacola, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sacred Heart Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Baptist Hospital
mi
from
Pensacola, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Baptist Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Pepin Heart Hospital
mi
from
Tampa, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Pepin Heart Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Winter Haven Hospital
mi
from
Winter Haven, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Winter Haven Hospital
mi
from
Winter Haven, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Redmond Regional Hospital
mi
from
Rome, GA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Redmond Regional Hospital
mi
from
Rome, GA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Advocate Good Shephard Hospital
mi
from
Barrington, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Rush University Medical Center
mi
from
Chicago, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Jesse Brown VA Medical Center
mi
from
Chicago, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Heartland Education and Research Foundation
mi
from
Joliet, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Heartland Education and Research Foundation
mi
from
Joliet, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Heart Care Research Foundation
mi
from
Mokena, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Heart Care Research Foundation
mi
from
Mokena, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Midwest Cardiovascular Research and Education Foundation
mi
from
Elkhart, IN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Midwest Cardiovascular Research and Education Foundation
mi
from
Elkhart, IN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Vincent Hospital/ Providence Heart Hospital
mi
from
Portland, OR
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Vincent Hospital/ Providence Heart Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Northwest Indiana Cardiovascular Physicians, P.C.
mi
from
Valparaiso, IN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Northwest Indiana Cardiovascular Physicians, P.C.
mi
from
Valparaiso, IN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Luke's Hospital - Cedar Rapids
mi
from
Cedar Rapids, IA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Luke's Hospital - Cedar Rapids
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Kings Daughters Medical Center
mi
from
Ashland, KY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Kings Daughters Medical Center
mi
from
Ashland, KY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Northeast Cardiology Associates
mi
from
Bangor, ME
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Northeast Cardiology Associates
mi
from
Bangor, ME
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Union Memorial Hospital
mi
from
Baltimore, MD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Shah Associates, MD, LLC
mi
from
Prince Frederick, MD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Shah Associates, MD, LLC
mi
from
Prince Frederick, MD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Peninsula Regional Medical Center
mi
from
Salisbury, MD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Peninsula Regional Medical Center
mi
from
Salisbury, MD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Washington Adventist Hospital
mi
from
Takoma Park, MD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Washington Adventist Hospital
mi
from
Takoma Park, MD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Cape Cod Hospital
mi
from
Hyannis, MA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Cape Cod Hospital
mi
from
Hyannis, MA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Bay Regional Medical Center
mi
from
Bay City, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Bay Regional Medical Center
mi
from
Bay City, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Harper University Hospital
mi
from
Detroit, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Harper University Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Borgess Medical Center
mi
from
Kalamazoo, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Borgess Medical Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Covenant Medical Center
mi
from
Saginaw, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Great Lakes Heart & Vascular Institute, PC
mi
from
St. Joseph, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Great Lakes Heart & Vascular Institute, PC
mi
from
St. Joseph, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Munson Medical Center
mi
from
Traverse City, MI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Mayo Clinic - Saint Marys Hospital
mi
from
Rochester, MN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Mayo Clinic - Saint Marys Hospital
mi
from
Rochester, MN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Central Minnesota Heart Center at St. Cloud Hospital
mi
from
St. Cloud, MN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Central Minnesota Heart Center at St. Cloud Hospital
mi
from
St. Cloud, MN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Hattiesburg Clinic
mi
from
Hattiesburg, MS
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Cardiology Associates Research LLC
mi
from
Tupelo, MS
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Cardiology Associates Research LLC
mi
from
Tupelo, MS
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Kansas City Heart Foundation
mi
from
Kansas City, MO
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Kansas City Heart Foundation
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Nebraska Heart Institute
mi
from
Lincoln, NE
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Nebraska Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials